MAPT and Alzheimer disease: There is a strong correlation between YKL-40 and markers of neurodegeneration (total tau and p-tau), as well as a negative correlation between YKL-40 and cortical thickness (CTh) in AD-vulnerable areas in Aβ42+ subjects [51].